Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Thomas Pierre Walter

PhD, HDR

Centre de Recherche en Cancérologie de Lyon

France

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in France

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Collaborators (18)

Dominik T. Schneider

Witten/Herdecke University

GERMANY

View details

Maria Ouzounova

Centre de Recherche en Cancérologie de Lyon

FRANCE

View details

Marco Volante

ITALY

View details

Maeve Lowery

Professor of Translational Cancer Medicine

Trinity College Dublin

IRELAND

View details

Eric Pasmant

Head

Institut Curie

FRANCE

View details

Rosalyn Juergens

CANADA

View details

Luka Brcic

Medical University of Graz

AUSTRIA

View details

Philippe Baltzinger

senior clinical lecturer

strasbourg university hospital

FRANCE

View details

Brivael Hémon

Enseignant-chercheur

École des Hautes Études en Santé Publique

FRANCE

View details

Benjamin Gibert

Centre de Recherche en Cancérologie de Lyon

FRANCE

View details

Lynnette Fernandez-Cuesta

Computational Cancer Genomics Team leader

International Agency for Research on Cancer

FRANCE

View details

Dagfinn Aune

Associate Professor

NORWAY

View details

Matthieu Foll

Team Leader

International Agency for Research on Cancer

FRANCE

View details

Jean-François CV OBADIA

Professor of Cardiothoracic Surgery

Hospices Civils de Lyon

FRANCE

View details

JULIEN MAZIERES

PROFESSOR

FRANCE

View details

Calogero Virgone

Associate Professor

University of Padova

ITALY

View details

Come Lepage

Université de Bourgogne

FRANCE

View details

Gianni Bisogno

Docenti di ruolo di Ia fascia

University of Padova

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Thomas Pierre Walter

Research Interests

Make your next move.

Explore related searches

Articles (20)

European Standard Clinical Practice Guideline and EXPeRT Recommendations for the Diagnosis and Management of Gastroenteropancreatic Neuroendocrine Neoplasms in Children and Adolescents

Lung carcinoids (lung neuroendocrine tumors): integrated classification, molecular biology, diagnosis, and multidisciplinary management

Nivolumab ± Ipilimumab in Patients With Pretreated Advanced Neuroendocrine Carcinoma: The GCO-001 NIPINEC Randomized Phase II Trial

Deep molecular profiling of lung neuroendocrine tumours and supra-carcinoids

Neuroendocrine tumours through an epigenetic lens: Emerging insights for diagnosis and treatment

Clinical and Pathological Features of EC-cell Familial Small Intestine Neuroendocrine Tumors: A Nationwide Cohort From the French GTE-RENATEN Network

Transcatheter Valve Replacement in Carcinoid Heart Disease: A Potential Change of Paradigm

Long-read sequencing identifies aberrant fragmentation patterns linked to elevated cell-free DNA levels in cancer

[&lt;sup&gt;177&lt;/sup&gt;Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

[<sup>177</sup>Lu]Lu-dota-tate versus sunitinib in patients with metastatic progressive neuroendocrine tumours of the pancreas (OCLURANDOM): a randomised, controlled, phase 2 trial.

Large Language Models for Patient Education: Insights from Cross-Lingual Expert Evaluation in Radioligand Therapy for Neuroendocrine Tumors.

Neuroendocrine Tumors and Pregnancy: The French PregNET Study.

European Society of Neuroendocrine Tumors ( <scp>ENETS</scp> ) 2025 guidance paper for lung and thymic carcinoids

Surgical Management of Zollinger‐Ellison Syndrome in Multiple Endocrine Neoplasia Type 1 an AFCE and GTE Cohort Study. (Association Francophone de Chirurgie Endocrinienne and Groupe d'étude des Tumeurs Endocrines)

The European Prospective Investigation into Cancer and Nutrition Cohort (EPIC): a gateway to rare cancer epidemiological research.

Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study

Belzutifan for Advanced Pheochromocytoma or Paraganglioma.

PRRT plus holmium‐166‐SIRT (HEPAR PLuS) versus PRRT‐only in patients with metastatic neuroendocrine tumors: A propensity‐score matched analysis

Response to systemic treatments and survival of fibrolamellar carcinomas: An AGEO-SFCE French multicenter retrospective cohort.

Proof of concept and design of an externally controlled trial for patients with gastro-enteropancreatic neuroendocrine carcinomas based on the randomized phase II BEVANEC trial.

Collaborators (18)

Dominik T. Schneider

Maria Ouzounova

Marco Volante

Maeve Lowery

Eric Pasmant

Rosalyn Juergens

Luka Brcic

Philippe Baltzinger

Brivael Hémon

Benjamin Gibert

Lynnette Fernandez-Cuesta

Dagfinn Aune

Matthieu Foll

Jean-François CV OBADIA

JULIEN MAZIERES

Calogero Virgone

Come Lepage

Gianni Bisogno

Make your next move.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.